Phase III Intergroup Study of Talc Poudrage vs Talc Slurry Sclerosis for Malignant Pleural Effusion Dresler, Carolyn M. , Olak, Jemi , Herndon, James E. ... - - Chest - 2005 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-9334
The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from Cancer and Leukemia Group B 9480. George, Daniel J , Halabi, Susan , Shepard, Timothy F , Sanford, Ben ... - - Clin. Cancer Res. - 2005 Manuscript - Primary Endpoint - Primary Analysis - GU - INT-0159
Prospective Phase II Trial of Pre-Resection Thoracoscopic (VATS) Restaging Following Neoadjuvant Therapy For IIIA(N2) Non-small Cell Lung Cancer (NSCLC): Results of CALGB 39803 Jaklitsch, M. T. , Gu, L. , Harpole, D. H. , D'Amico, T. A. ... - - J. Clin. Oncol. - 2005 Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-39803
Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: The Cancer and Leukemia Group B (study 9730). Lilenbaum, Rogerio C , Herndon, James E , List, Marcy A ... - - J. Clin. Oncol. - 2005 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-9730
Preliminary Analysis of Cancer and Leukemia Group B (CALGB) 80003: A Phase II Trial of Gemcitabine, 5-Fluorouracil (5FU), and Radiation Therapy (RT) in Locally Advanced Non-Metastatic Pancreatic Adenocarcinoma Mamon, H. J. , Niedzwiecki, D. , Hollis, D. R. , Tan, B. , Smith, J. ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2005 Abstract - Primary Endpoint - Preliminary Analysis - GI - CALGB-80003
A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer: Cancer and Leukemia Group B Study (9235). McClay, Edward F , Bogart, Jeff , Herndon, James E , Watson, Dee ... - - Am. J. Clin. Oncol. - 2005 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-9235
Combined-modality therapy of poor prognosis anal canal carcinoma: a phase II study of the Cancer and Leukemia Group B (CALGB) Meropol, N. J. , Niedzwiecki, D. , Shank, B. , Colacchio, T. ... - ASCO GI - Gastrointestinal Cancers Symposium - 2005 Abstract - Primary Endpoint - Primary Analysis - GI - CALGB-9281
Phase II trial of paclitaxel-topotecan-etoposide (PTE) followed by consolidation chemoradiotherapy for limited stage small cell lung cancer (LS-SCLC): CALGB 30002 Miller, A. A. , Bogart, J. A. , Watson, D. M. , Wang, X. F. ... - - J. Clin. Oncol. - 2005 Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30002
Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222 Moore, Joseph O. , George, Stephen L. , Dodge, Richard K. ... - - Blood - 2005 Manuscript - Primary Endpoint - Primary Analysis - Leukemia - CALGB-9222
Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732. Niell, Harvey B , Herndon, James E , Miller, Antonius A ... - - J. Clin. Oncol. - 2005 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - C9732
Updated analysis of a Phase III study of surgical resection and chemotherapy (paclitaxel/carboplatin) (CT) with or without adjuvant radiation therapy (RT) for resected stage III non-small cell lung cancer (NSCLC) CALGB 9734 Perry, M. C. , Kohman, L. , Bonner, J. , Gu, L. , Wang, X. , Vokes, E. ... - - J. Clin. Oncol. - 2005 Abstract - Primary Endpoint - Long-Term-Followup Analysis - Respiratory - CALGB-9734
Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13. Peters, William P , Rosner, Gary L , Vredenburgh, James J ... - - J. Clin. Oncol. - 2005 Manuscript - Primary Endpoint - Primary Analysis - Breast - CALGB-9082
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. Romond, Edward H , Perez, Edith A , Bryant, John , Suman, Vera J ... - - N. Engl. J. Med. - 2005 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Breast - N9831
CALGB 30103: A randomized phase II study of carboplatin and etoposide (CE) with or without G3139 in patients with extensive stage small cell lung cancer (ES-SCLC). Rudin, C. M. , Salgia, R. , Wang, X. F. , Green, M. R. ... - - J. Clin. Oncol. - 2005 Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30103
A Phase II Study of Carboplatin, Etoposide and Exisulind in Patients with Extensive Stage Small Cell Lung Cancer: CALGB 30104 Wang, X. F. , Govindan, R. , Herndon, J. E., 2nd , Barrier, R. C. ... - - J. Clin. Oncol. - 2005 Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30104
